EXCLUSIVE LIVE EVENT:
Join us for a special edition of Share the Science featuring Dr. Joanne Kurtzberg at this year’s AABB Annual Meeting in San Diego, California.
Dr. Joanne Kurtzberg is recognized around the world for her outstanding work in cord blood research. In recent years, her research has been focused on using cord blood to potentially treat autism in young children. As the results from her clinical trials have started to come in, the medical world and parents have taken notice. She was recently interviewed by CNN along with her colleague, Dr. Geraldine Dawson, Director of Duke’s Center for Autism and Brain Development, about the encouraging results from these clinical trials. With more than two-thirds of children showing improvement, Dr. Kurtzberg and her team are now moving into phase two hoping to find a long-term treatment option for children with autism.
According to Dr. Kurtzberg, cord blood cells can work through paracrine and trophic mechanisms to help endogenous cells heal brain tissue damaged by disease or injury. Learning from observations made using unrelated donor umbilical cord blood transplant after myeloablative chemotherapy to treat children with certain inherited metabolic diseases, cord blood therapies have been developed to treat children with acquired brain injuries, like hypoxic ischemic encephalopathy, cerebral palsy, and autism.
As the research moves forward and new clinical trials begin, Dr. Kurtzberg has agreed to speak with our Share the Science community about the safety and feasibility of using autologous cord blood infusion in young children with autism spectrum disorder. She will also expand her talk into other areas of possible clinical application for cord blood therapies. Join us for this exclusive live event at the AABB Annual Meetings in San Diego, California.
Share the Science LIVE at AABB
Dr. Joanne Kurtzberg
“Novel applications of cord blood derived therapies
for genetic and acquired brain diseases.”
San Diego Convention Center: Room 29B
San Diego, CA | MONDAY, OCTOBER 9, 2017| 7 a.m. – 8:15 a.m. PACIFIC TIME
Free to register. Open to all.
Data from early phase human clinical trials for safety and efficacy in these diseases will be presented by Dr. Kurtzberg. Results of preclinical and IND-enabling studies will be presented to provide information about safety and potential mechanisms of action of cord blood cells in this setting.
In addition, attendees will learn about:
- The history and evolution of cord blood banking and transplant
- About quality measures of cord blood units
- About new clinical applications for cord blood therapies
About the speaker
Joanne Kurtzberg, MD is the Director, Pediatric Blood and Marrow Transplant Program, Chief Scientific and Medical Officer, Robertson Clinical and Translational Cell Therapy Program, Director, Carolinas Cord Blood Bank and Co-Director, Stem Cell Laboratory.
She is an internationally renowned expert in pediatric hematology/oncology, pediatric blood and marrow transplant, umbilical cord blood banking and transplant, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine.
Over the last two decades, Dr. Kurtzberg has established an internationally known pediatric transplant program; one of the largest unrelated donor cord blood banks, the Carolinas Cord Blood Bank, in the world; and the Julian Robertson Cell and Translational Therapy Program (CT2) at Duke.
Dr. Kurtzberg has published more than 300 peer-reviewed papers, multiple chapters, and scientific reviews. She is a member of the American Society of Hematology, the American Association of Blood and Marrow Transplantation, the American Society of Pediatric Hematology/Oncology, the International Society of Cellular Therapies, the Pediatric Blood and Marrow Transplant Consortium (PBMTC), and other organizations. She serves on the Board of the Foundation of Accreditation of Cellular Therapies, Advisory Council of Blood Stem Cell Transplantation to Health and Human Services. Dr. Kurtzberg was awarded a Lifetime Achievement Award from the PBMTC in 2012.
We wish to thank Dr. Kurtzberg for sharing her
valuable insight on cord blood research for autism
with our Share the Science community.
We also wish to thank Mediware, Inc.
for their generous support making this webinar possible.
Share the Science continues to be a popular series within the cord blood community and beyond. We welcome your input on the series and suggestions for future speakers. Give your feedback here.
Share the Science is made possible thanks to the generous support of Mediware, Inc.